Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial

Sylvain A. Lother, Wen Teng, Olawale Ayilara, Brett L. Houston, Barret Rush, Srinivas Murthy, Jose C. Nicolau, Lindsay Bond, Alexis F. Turgeon, John C. Marshall, Jonathan Paul, Judith S. Hochman, Matthew D. Neal, Michael E. Farkouh, Joel Nkosi, Donald S. Houston, Charlotte A. Bradbury, Asher A. Mendelson, Ewan C. Goligher, Allan Garland, Robert Balshaw, Souradet Y. Shaw, Patrick R. Lawler, Yoav Keynan, Ryan Zarychanski

Open source

DOI: 10.1016/j.rpth.2025.102893
Published: 2025-05
Container: Research and Practice in Thrombosis and Haemostasis
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.rpth.2025.102893,
  title = {Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial},
  author = {Sylvain A. Lother and Wen Teng and Olawale Ayilara and Brett L. Houston and Barret Rush and Srinivas Murthy and Jose C. Nicolau and Lindsay Bond and Alexis F. Turgeon and John C. Marshall and Jonathan Paul and Judith S. Hochman and Matthew D. Neal and Michael E. Farkouh and Joel Nkosi and Donald S. Houston and Charlotte A. Bradbury and Asher A. Mendelson and Ewan C. Goligher and Allan Garland and Robert Balshaw and Souradet Y. Shaw and Patrick R. Lawler and Yoav Keynan and Ryan Zarychanski},
  year = {2025},
  journal = {Research and Practice in Thrombosis and Haemostasis},
  doi = {10.1016/j.rpth.2025.102893},
  url = {https://doi.org/10.1016/j.rpth.2025.102893}
}

RIS

TY  - JOUR
TI  - Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial
AU  - Sylvain A. Lother
AU  - Wen Teng
AU  - Olawale Ayilara
AU  - Brett L. Houston
AU  - Barret Rush
AU  - Srinivas Murthy
AU  - Jose C. Nicolau
AU  - Lindsay Bond
AU  - Alexis F. Turgeon
AU  - John C. Marshall
AU  - Jonathan Paul
AU  - Judith S. Hochman
AU  - Matthew D. Neal
AU  - Michael E. Farkouh
AU  - Joel Nkosi
AU  - Donald S. Houston
AU  - Charlotte A. Bradbury
AU  - Asher A. Mendelson
AU  - Ewan C. Goligher
AU  - Allan Garland
AU  - Robert Balshaw
AU  - Souradet Y. Shaw
AU  - Patrick R. Lawler
AU  - Yoav Keynan
AU  - Ryan Zarychanski
PY  - 2025
JO  - Research and Practice in Thrombosis and Haemostasis
DO  - 10.1016/j.rpth.2025.102893
UR  - https://doi.org/10.1016/j.rpth.2025.102893
ER  -

APA

Lother, S. A., Teng, W., Ayilara, O., Houston, B. L., Rush, B., Murthy, S., Nicolau, J. C., Bond, L., Turgeon, A. F., Marshall, J. C., Paul, J., Hochman, J. S., Neal, M. D., Farkouh, M. E., Nkosi, J., Houston, D. S., Bradbury, C. A., Mendelson, A. A., Goligher, E. C., Garland, A., Balshaw, R., Shaw, S. Y., Lawler, P. R., Keynan, Y., & Zarychanski, R. (2025). Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial. Research and Practice in Thrombosis and Haemostasis. https://doi.org/10.1016/j.rpth.2025.102893

Source records

crossref · retrieved 2026-09-27T01:29:35.169Z